ꢀ
ꢀ
88
P. Troselj, I. Đilović, D. Matković-Calogović, and D. Margetić
Vol 50
General procedure for OD cycloadditions. Method A -
1,11-Bis(trifluoromethyl)-6,16-diethyl-1a,2b,3a,4a,8a,9a,
10b,11a,12b,13a,14a,18a,19a,20b-6,16-diaza-22-oxaoctacyclo
[9.9.11,11.13,9.113,19.02,10.04,8.012,20.014,18]tricosa-5,7,15,17-tetraone
dicarboxylate (29). Method B (MeCN, 20%), 1H-NMR (CDCl3), d/
ppm (obtained from crude mixture): 1.39 (2H, d, J=10.5Hz), 2.23
(4H, s), 2.29 (2H, d, J= 10.5 Hz), 3.05 (4H, s), 3.09 (4H, s), 4.24
(4H, s), 7.35 (2H, br s).
microwave. Mixture of oxadiazole 1a (60 mg, 0.25 mmol) and
substrate (50–100 mg, 0.05mmol) in appropriate solvent was
subjected to microwave-assisted reaction at 140–170ꢀC. Reactions
were conducted in CEM DiscoverWLabmateTH/ExplorerPLSW
single mode microwave reactor using closed reaction vessel
technique (power= 125 W). Excess of solvent was removed in
vacuo, and products were analyzed by either by TLC or 1H-NMR
spectroscopy. Radial chromatography (with petroleum ether–ethyl
acetate) was used to isolate pure products.
1,16-Bis(trifluoromethyl)-5,12,20,27-tetramethoxy-(1a,2b,3a,
4b,5a,12a,13b,14a,15b,16a,17b,18a,19b,20a,27a,28b,29a,
30b)-33-oxadodecacyclo[14.14.1.13,141.15,12.118,29.120,27.02,15.04,13
.06,11.017,30.019,28.021,26]pentatriaconta-4,6,8,10,12,19,21,23,25,27-
decaene (10). Method A (15%), method B (95%), (mp 187–191ꢀC).
1H-NMR (CDCl3), d/ppm: 1.63 (2H, dd, J = 9.8 Hz), 2.33 (4H, s),
2.58 (2H, dd, J = 9.8Hz), 3.95 (12H, s), 4.09 (4H, s), 7.41 (4H,
dd, J = 6.0 Hz, J = 2.8 Hz), 8.01 (4H, dd, J = 6.0 Hz, J = 2.8 Hz);
General procedure for OD cycloadditions. Method B -
thermal. Mixture of oxadiazole 1a (100 mg, 0.42 mmol) and
substrate (100–150 mg, 0.05–0.1 mmol) in THF (2–3 mL) was
heated in a sealed glass tube. Upon cooling, solvent and escess
reagent were removed in vacuo, and products were purified by
radial chromatography (with petroleum ether–ethyl acetate).
1,11-Bis(20-ethylphthalimido)-6,16-bis(ethyl)-1a,2b,3a,4a,
8a,9a,10b,11a,12b, 13a,14a,18a,19a,20b-6,16-diaza-22-
oxaoctacyclo[9.9.11,11.13,9.113,19.02,10.04,8.012,20.014,18]tricosane-
5,7,15,17-tetraone (20). Method B with 16 (40%), (mp 263–264ꢀC).
1H-NMR (CDCl3), d/ppm: 1.23 (2H, dd, J=7.5Hz, J= 4.9 Hz), 2.26
(2H, dd, J=7.5Hz, J= 4.9 Hz), 2.79 (4H, s), 2.92 (4H, s), 3.55
(4H, t, J= 7.1 Hz), 4.01 (4H, t, J= 7.1 Hz); 7.57–7.97 (8H, m);
13C-NMR (CDCl3), d/ppm: 28.1, 38.2, 38.7, 40.7, 48.2, 49.3, 88.5
2
13C-NMR (CDCl3), d/ppm: 41.4, 42.0, 54.8, 61.2, 87.1 (q, JC,
1
F = 31.5 Hz), 121.5, 124.9, 123.5 (q, JC,F = 276.8 Hz), 127.7,
133.5, 143.9; HRMS (m/z): Calcd for C38H32O5F6: 682.2154
found: 682.2157.
1-Methyl-16-trifluoromethyl-5,12,20,27-tetramethoxy-(1a,2b,
3a,4b,5a,12a,13b,14a,15b,16a,17b,18a,19b,20a,27a,28b,29a,
30b)-33-oxadodecacyclo[14.14.1.13,14.1.15,12.118,29.120,27.02,15.04,13
.06,11.017,30.019,28.021,26]pentatriaconta-4,6,8,10,12,19,21,23,25,27-
decaene-1-carboxylate (15). Method A (98%), method B (96%),
(mp 211–213ꢀC). 1H-NMR (CDCl3), d/ppm: 1.56 (2H, dd,
J=5Hz, J= 2 Hz), 2.31 (2H, dd, J=5Hz, J= 2 Hz), 2.42 (2H, dd,
J=5 Hz, J= 2 Hz), 2.71 (2H, dd, J=5Hz, J= 2 Hz), 3.66 (4H, s),
3.95 (6H, s), 4.1 (6H, s), 4.2 (3H, s), 4.2 (4H, s), 7.41 (2H, dd,
J=5.0Hz, J = 2.0 Hz), 8.00 (2H, dd, J = 5 Hz, J = 2 Hz); 13C-
NMR (CDCl3), d/ppm: 41.3, 42.1, 44.1, 52.0, 54.6, 54.8,
2
1
(q, JC,F = 31.3 Hz), 123.4, 124.2 (q, JC,F = 278.1 Hz), 131.8, 134.2,
168.6, 176.9, HRMS (m/z): Calcd for C42H32O9N4F6: 850.2073
found: 850.2077.
Bisalkylation method. Mixture of imide 17 (62 mg, 0.123 mmol),
N-(2-bromoethyl)phthalimide 18 (80 mg, 0.316 mmol), and potassium
carbonate (20 mg, 0.145 mmol) in DMF (1.5 mL) was heated at 65ꢀC
for 48 h. Solvent was removed in vacuo, residue dissolved in
dichloromethane and washed with water. Organic layers were
separated, dried (MgSO4), and solvent removed in vacuo to afford
colorless solid (98.3 mg, 94%).
2
60.7, 61.0, 81.1, 87.2 (q, JC,F = 31.1 Hz), 121.3, 121.4,
1
124.6, 124.8, 123.7 (q, JC,F = 277.0 Hz), 127.8, 127.9, 133.4,
133.7, 143.8, 144.0, 161.6; HRMS (m/z): Calcd for C39H35O5F3:
640.2436 found: 640.2349.
4-(20-(2,5-Bis(trifluoromethyl)-1,3,4-oxadiazolo)aminoethyl)-
(1a,2b,3b,6b,7b,8a)-15-Oxapentacyclo[6.6.1.13,6.02,7.09,14
]
1a,2a,6a,7a-4-azatricyclo[5.2.1.02,6]deca-8-ene-3,5-dione
(26). Method B with 22 (86%), method B with 23 (90%), (mp 177–
178ꢀC). 1H-NMR (CDCl3), d/ppm: 1.58 (1H, dd, J=8.6Hz,
J= 2.3 Hz), 1.93 (1H, dd, J=8.6Hz, J= 2.3 Hz), 3.30 (2H, s), 3.38
(2H, s), 3.78 (2H, t, J= 6.4 Hz), 4.33 (2H, t, J= 6.4 Hz), 6.08 (2H,
s); 13C-NMR (CDCl3), 36.9, 44.5, 44.8, 45.9, 52.2, 67.9, 117.8 (q,
tetradeca-4,9,11,13-tetraene (32). Solution of 7-oxabenzonor-
bornadiene 30 (1.00 g, 6.94 mmol) in chloroform (5mL) and
freshly cracked cyclopentadiene (2.00 g, 30.3 mmol) was heated at
70ꢀC for 18 h in sealed glass tube. Solvent was removed in vacuo,
and oily residue was separated by flash column chromatography
(silicagel, petroleum ether, then solvent polarity was increased to
2
1JC,F = 293.1 Hz), 134.6, 146.9 (q, JC,F = 41.4 Hz), 175.9; d/ppm:,
1
5% ethyl acetate) to afford colorless oil (1.30 g, 89.0%). H-NMR
HRMS (m/z): Calcd for C15H12O2N4F6: 394.0864 found: 394.0861.
1,11-Bis(trifluoromethyl)-6,16-bis(20-benzyloxycarbony-
laminoethyl)-1a,2b,3a,4a,8a,9a,10b,11a,12b,13a,14a,18a,
19a,20b-6,16-diaza-22-oxaoctacyclo[9.9.11,11.13,9.113,19.02,10
.04,8.012,20.014,18]tricosane-5,7,15,17-tetraone dicarboxylate
(27). Method A (50%), method B (30%), 1H-NMR (CDCl3),
d/ppm (obtained from crude mixture): 1.25 (2H, d, J = 8.6 Hz),
2.20 (4H, s), 2.30 (2H, dd, J = 8.6 Hz, J = 1.7 Hz), 2.74 (4H, s),
2.84 (4H, s), 3.25–3.27 (4H, m), 3.46 (4H, t, J = 6.0 Hz), 5.05
(4H, s), 7.25–7.39 (10H, m); HRMS (m/z): Calcd for
C42H40O9N4F6: 858.2699 found: 858.2701.
(CDCl3), d/ppm: 1.38 (1H, d, J = 8.1 Hz), 1.56 (1H, td, J= 8.1Hz,
J = 1.7 Hz), 2.38 (2H, t, J = 1.7 Hz), 2.92 (2H, t, J= 1.4Hz), 4.97
(2H, s), 6.14 (2H, t, J= 1.7Hz), 7.09 (4H, dd, J = 5.4 Hz,
J = 3.2 Hz), 7.18 (4H, dd, J = 5.4 Hz, J =3.2Hz); 13C-NMR
(CDCl3), d/ppm: 44.4, 49.4, 53.7, 80.2, 118.9, 126.5, 134.4,
148.4; HRMS (m/z): Calcd for C15H14O1: 210.1045 found:
210.1046.
11,12-Dibromo-(1a,2b,3b,6b,7b,8a)-15-oxapentacyclo[6.6.1
.13,6.02,7.09,14]tetradeca-4,9,11,13-tetraene (33). Solution of 4,5-
dibromo-7-oxabenzonorbornadiene 31 (1.00 g, 3.33 mmol) in
chloroform (5mL) and freshly cracked cyclopentadiene (2.00 g,
30.3mmol) was heated at 80ꢀC for 18h in sealed glass tube.
Solvent was removed in vacuo, and oily residue was separated
by flash column chromatography (silicagel, petroleum ether,
then solvent polarity was increased to 5% ethyl acetate) to
afford colorless solid (0.94 g, 77%, mp 213–214ꢀC). 1H-NMR
(CDCl3), d/ppm: 1.36 (1H, d, J = 8.2 Hz), 1.55 (1H, td, J = 8.2 Hz,
J = 1.6Hz), 2.36 (2H, dd, J = 2.6 Hz, J = 1.3 Hz), 2.92 (2H, t,
J = 1.6Hz), 4.92 (2H, s), 6.09 (2H, t, J = 1.5 Hz), 7.41 (4H, s);
13C-NMR (CDCl3), d/ppm: 43.9, 48.6, 53.3, 79.4, 121.8, 123.9,
1,11-Bis(trifluoromethyl)-6,16-bis(20-piperidinoaminoethyl)-
1a,2b,3a,4a,8a,9a,10b,11a,12b,13a,14a,18a,19a,20b-6,16-
diaza-22-oxaoctacyclo[9.9.11,11.13,9.113,19.02,10.04,8.012,20.014,18
]
tricosane-5,7,15,17-tetraone dicarboxylate (28). Method
B
(20%), 1H-NMR (CDCl3), d/ppm (obtained from crude mixture):
1.33 (2H, d, J = 10.5 Hz), 1.72 (4H, s), 2.21 (2H, d, J = 10.5 Hz),
2.87 (8H, t, J = 7.1 Hz), 2.89 (4H, s), 3.19 (4H, s), 3.59 (4H,
t, J = 6.6Hz), 3.66 (4H, t, J = 6.6Hz), 3.70 (4H, t, J = 7.1 Hz), 3.72
(8H, t, J = 7.1Hz).
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet